EphA5

EphA5

EphA5 詳細

Molecule Name
EPH Receptor A5
分子の別称
Ephrin type-A receptor 5
Drug Development Progress
治験薬の数1
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
EPHA5,BSK,EphA5,EC 2.7.10,Receptor Protein-Tyrosine Kinase HEK7,Tyrosine-Protein Kinase Receptor EHK-1,Epididymis Secretory Sperm Binding Protein,EK7,Hek7,EHK-1,EC 2.7.10.1,EPH-like kinase 7,EPH-Like Kinase,EPH homology kinase 1,Brain-Specific Kinase,EPH Homology Kinase,Ephrin type-A receptor 5,Ephrin Type-A Receptor,HEK7,CEK7,EHK1,TYRO4
バックグランド
Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance.

EphA5 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
MBRC-101MBRC-101Phase 2 ClinicalMBrace Therapeutics Inc
Neoplasms
詳細